Protein glycosylation is essential for SARS-CoV-2 infection
Casas-Sanchez, A.; Romero-Ramirez, A.; Hargreaves, E.; Patterson, E. I.; Hughes, G. L.; Zech, T.; Acosta-Serrano, A.
10.1101/2021.02.05.429940 bioRxivShow abstract
SARS-CoV-2 extensively N-glycosylates its spike proteins, which are necessary for host cell invasion and the target of both vaccines and immunotherapies. These sugars are predicted to help mediate spike binding to the host receptor by stabilizing its open conformation and evading host immunity. Here, we investigated both the essentiality of the host N-glycosylation pathway and SARS-CoV-2 N-glycans for infection. Inhibition of host N-glycosylation using RNAi or FDA-approved drugs reduced virus infectivity, including that of several variants. Under these conditions, cells produced less virions and some completely lost their infectivity. Furthermore, partial deglycosylation of intact virions showed that surface-exposed N-glycans are critical for cell invasion. Altogether, spike N-glycosylation is a targetable pathway with clinical potential for treatment or prevention of COVID-19.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The TMPRSS2 non-protease domains regulating SARS-CoV-2 Spike in mediated virus entry 95%
- TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection 94%
- Cell culture model system utilizing engineered A549 cells to express high levels of ACE2 and TMPRSS2 for investigating SARS-CoV-2 infection and antivirals 94%
Similar papers in this journal
- Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response 95%
- Thiopurines activate an antiviral unfolded protein response that blocks viral glycoprotein accumulation in cell culture infection model 95%
- The spike-stabilizing D614G mutation interacts with S1/S2 cleavage site mutations to promote the infectious potential of SARS-CoV-2 variants 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.